MedPath

Cefotan

CEFOTAN(Cefotetan for injection, USP)

Approved
Approval ID

0860bfe0-da3e-4460-da57-2411db14c426

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2018

Manufacturers
FDA

Teligent Pharma, Inc.

DUNS: 011036910

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

cefotetan disodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52565-053
Application NumberNDA050588
Product Classification
M
Marketing Category
C73594
G
Generic Name
cefotetan disodium
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateFebruary 27, 2018
FDA Product Classification

INGREDIENTS (1)

Cefotetan DisodiumActive
Quantity: 2 g in 20 mL
Code: 0GXP746VXB
Classification: ACTIM

Cefotetan Disodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52565-052
Application NumberNDA050588
Product Classification
M
Marketing Category
C73594
G
Generic Name
Cefotetan Disodium
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateFebruary 27, 2018
FDA Product Classification

INGREDIENTS (1)

Cefotetan DisodiumActive
Quantity: 1 g in 10 mL
Code: 0GXP746VXB
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefotan - FDA Drug Approval Details